Cover Image
Market Research Report
Product code 
1026472

North America Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Prescription Mode, and End User

Published: | The Insight Partners | 178 Pages | Delivery time: 1-2 business days

Price

Back to Top
North America Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Prescription Mode, and End User
Published: July 13, 2021
The Insight Partners
Content info: 178 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The North America point of care diagnostics market is expected to grow from US$ 16,612.40 million in 2021 to US$ 38,702.11 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028.

Increasing product launches and product developments is to drive the market growth. The number of point-of-care testing has steadily increased over the last 40 years since its widespread introduction. The point of care market is likely to grow with the introduction of new products into the market, aimed at delivering inexpensive care at the facilities located at the closest-possible distances from the patients' location. New technologies or products are being refined and improved to deliver easier to use devices with incremental improvements in analytical performance. The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular testing. Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Moreover, in July 2021, BD announced launch of rapid and portable point-of-care antigen test for diagnosis of COVID-19. The new test kit is capable to deliver results within 15 minutes of the test. Besides, in December 2020, Beckman Coulter also introduced its rapid antigen kit for diagnosis of COVID-19. Similarly, in 2017, Roche Diagnostic division launched CoaguChek Vantus PoC in the US; this system enables handheld coagulation monitoring system for the self-assessment of health. The division has also launched new point-of-care mobile application Cobas Infinity designed to meet the needs of point-of-care coordinators to manage important tasks on the go. Such advancements in new launched devices will propel the overall North America POC market growth during the forecast period.

In case of COVID-19, North America is highly affected specially the US. The outbreak of the COVID-19 pandemic situation shown some favorable scenario for players operating in the point of care diagnostics market. Significant population of North America is infected with coronavirus. For instance, the US is a highly affected country in the North American regions. The effect of the corona is mild in adults; however, it is adverse in older people. The infection of corona among older people has resulted in severe complications and has accounted for a good number of deaths in the country. But during the pandemic situation, life science companies engaged in development of novel drugs for the treatment of life threaten diseases. In addition, increasing demand for rapid testing equipment is also playing a prominent role in the growth of the North America point of care diagnostics market. Furthermore, due to the rising numbers of COVID-19 population has positive impact on the adoption of point of care diagnostic kits. This adoption is boosting new product development and launches in the market. For instance, in July 2020, Eurofins U.S. Clinical Diagnostics has announced the availability of its pooled PCR test to detect SARS-CoV-2, which would substantially lower the cost per PCR test for clients. Moreover, in March 2020, Abbott received FDA approval for its molecular point-of-care test for the diagnosis of COVID-19. The test is capable to deliver positive results in five minutes and negative result in less than fifteen minutes. Such product launches are expected to accelerate the growth of the North America point of care diagnostics market.

The glucose monitoring products segment led the North America point of care diagnostics market based on product in 2020. The North America glucose monitoring devices market consists of components such as glucometers, lancets, testing strips and other glucose monitoring devices. The glucose monitoring devices or glucose meters are medical devices are used to determine the approximate levels or the concentration of glucose in the blood of the patients living with diabetes. The concentration of the glucose level can be measured by various means such as through testing strips, lancets and others. In the market various market players have introduced their devices for the glucose monitoring. Therefore, owing to the presence of the various market players that are offering various products and rise in the technological advancements are likely to propel the growth of the North America market during the forecast period.

The overall North America point of care diagnostics market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the North America point of care diagnostics market. The process also serves the purpose of obtaining overview and forecast for the North America point of care diagnostics market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the North America point of care diagnostics market. Abbott; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; Johnson and Johnson Services, Inc.; Nova Biomedical; Polymer Technology Systems, Inc. (PTS); and Siemens AG are among a few players operating in the North America point of care diagnostics market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America point of care diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in North America point of care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the point of care diagnostics market, as well as those hindering it 
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution  
Table of Contents
Product Code: TIPRE00023729

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Point of Care Diagnostics Market - By Product
    • 1.3.2 North America Point of Care Diagnostics Market - By Prescription Mode
    • 1.3.3 North America Point of Care Diagnostics Market - By End User
    • 1.3.4 North America Point of Care Diagnostics Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Point of Care Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Point of Care Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Prevalence of Infectious Diseases
    • 5.1.2 Increasing Product Launches and Product Developments
    • 5.1.3 Rising Number of CLIA-waived POC tests
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls in Market
  • 5.3 Market Opportunities
    • 5.3.1 Burgeoning Number of Conferences and Events
  • 5.4 Future Trends
    • 5.4.1 Escalating Use of Home-Based POC Devices
  • 5.5 Impact Analysis

6. Point of Care Diagnostics Market - North America Analysis

  • 6.1 North America Point of Care Diagnostics Market Revenue Forecast and Analysis

7. North America Point of Care Diagnostics Market Analysis- by Product

  • 7.1 Overview
  • 7.2 North America Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
  • 7.3 Glucose Monitoring
    • 7.3.1 Overview
    • 7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.4 Infectious Disease Testing
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.3 HIV Testing
      • 7.4.3.1 Overview
      • 7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.4 Influenza Testing
      • 7.4.4.1 Overview
      • 7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.5 Sexually Transmitted Disease (STD) Testing
      • 7.4.5.1 Overview
      • 7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.6 Hepatitis C Testing
      • 7.4.6.1 Overview
      • 7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.7 Healthcare-Associated Infection (HAI) Testing
      • 7.4.7.1 Overview
      • 7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.8 Tropical Disease Testing
      • 7.4.8.1 Overview
      • 7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.9 Respiratory Infection Testing
      • 7.4.9.1 Overview
      • 7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    • 7.4.10 Other Infectious Disease
      • 7.4.10.1 Overview
      • 7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.5 Cardiometabolic Testing
    • 7.5.1 Overview
    • 7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.6 Pregnancy and Fertility Testing
    • 7.6.1 Overview
    • 7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.7 Coagulation Testing
    • 7.7.1 Overview
    • 7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.8 Tumor/Cancer Marker Testing
    • 7.8.1 Overview
    • 7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.9 Cholesterol Testing
    • 7.9.1 Overview
    • 7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.10 Urinalysis Testing
    • 7.10.1 Overview
    • 7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.11 Haematology Testing
    • 7.11.1 Overview
    • 7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
  • 7.12 Other POC
    • 7.12.1 Overview
    • 7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)

8. North America Point of Care Diagnostics Market Analysis- by Prescription Mode

  • 8.1 Overview
  • 8.2 North America Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
  • 8.3 Prescription-Based Testing Market
    • 8.3.1 Overview
    • 8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • 8.4 OTC Testing Market
    • 8.4.1 Overview
    • 8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)

9. North America Point of Care Diagnostics Market Analysis- by End User

  • 9.1 Overview
  • 9.2 North America Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
  • 9.3 Professional Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.3.3 Hospitals
      • 9.3.3.1 Overview
      • 9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.3.4 Clinical Laboratories
      • 9.3.4.1 Overview
      • 9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.3.5 Outpatient Healthcare
      • 9.3.5.1 Overview
      • 9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
    • 9.3.6 Ambulatory Care Settings
      • 9.3.6.1 Overview
      • 9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.4 Home Care
    • 9.4.1 Overview
    • 9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)

10. North America Point of Care Diagnostics Market - Country Analysis

  • 10.1 North America: Point of Care Diagnostics Market
    • 10.1.1 Overview
    • 10.1.2 North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
    • 10.1.3 US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.3.1 US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.3.2 US: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 10.1.3.2.1 US: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
      • 10.1.3.3 US: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
      • 10.1.3.4 US: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
        • 10.1.3.4.1 US: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
    • 10.1.4 Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.4.1 Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.4.2 Canada: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 10.1.4.2.1 Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
      • 10.1.4.3 Canada: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
      • 10.1.4.4 Canada: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
        • 10.1.4.4.1 Canada: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
    • 10.1.5 Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.5.1 Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.5.2 Mexico: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 10.1.5.2.1 Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
      • 10.1.5.3 Mexico: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
      • 10.1.5.4 Mexico: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
        • 10.1.5.4.1 Mexico: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

11. Impact of COVID-19 Pandemic on North America Point of Care Diagnostics Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Growth Strategies
    • 12.2.1 Overview
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 F. HOFFMANN-LA ROCHE LTD.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Danaher
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 BIO-RAD LABORATORIES INC.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Abbott
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Johnson and Johnson Services, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Siemens AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 BD
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 bioMerieux SA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Polymer Technology Systems, Inc. (PTS)
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Nova Biomedical
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Point of Care Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 3. US: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
  • Table 4. US: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
  • Table 5. US: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 6. US: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Canada: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
  • Table 9. Canada: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Canada: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Canada: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
  • Table 12. Mexico: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
  • Table 14. Mexico: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Mexico: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Mexico: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
  • Table 17. Recent Organic Developments the Point of Care Diagnostics Market
  • Table 18. Recent Inorganic Developments in the Point of Care Diagnostics Market
  • Table 19. Glossary of Terms

List Of Figures

  • Figure 1. North America Point of Care Diagnostics Market Segmentation
  • Figure 2. North America Point of Care Diagnostics Market Segmentation, By Country
  • Figure 3. North America Point of Care Diagnostics Market Overview
  • Figure 4. Prescription-Based Testing Segment Held Largest Share of Point of North America Care Diagnostics Market
  • Figure 5. US to Show Significant Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Impact Analysis of Driver and Restraints Pertaining to North America Point of Care Diagnostics Market
  • Figure 8. North America Point of Care Diagnostics Market - Revenue Forecast and Analysis
  • Figure 9. North America Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
  • Figure 10. North America Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. North America Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. North America HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 13. North America Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. North America Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. North America Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 16. North America Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. North America Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. North America Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 19. North America Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. North America Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 21. North America Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. North America Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. North America Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 24. North America Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. North America Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. North America Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 27. North America Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. North America Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
  • Figure 29. North America Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. North America OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. North America Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
  • Figure 32. North America Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 33. North America Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. North America Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. North America Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. North America Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. North America Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 38. North America Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 39. North America Others Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 40. North America: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
  • Figure 41. North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
  • Figure 42. US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 43. Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 44. Mexico Point of care diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 45. Impact of COVID-19 Pandemic in North American Country Markets